The next generation: strong, specialized.
Year: 2008
Type: article
Abstract: The first generation of RA biologics was good, but just the start. A new group of therapies - some novel, some familiar, but all powerful and each with a niche - will energize this market.
Source: PubMed Central
Author: John Carroll
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2419461049